Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $13.6 in the prior trading day, Calumet Inc (NASDAQ: CLMT) closed at $13.23, down -2.72%. In other words, the price has decreased by -$2.72 from its previous closing price. On the day, 0.71 million shares were traded. CLMT stock price reached its highest trading level at $13.6 during the session, while it also had its lowest trading level at $13.22.
Ratios:
Our goal is to gain a better understanding of CLMT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.45 and its Current Ratio is at 0.76.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on May 13, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On March 17, 2025, UBS Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $15 to $12.
TD Cowen Downgraded its Buy to Hold on March 04, 2025, whereas the target price for the stock was revised from $26 to $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when DANIEL J SAJKOWSKI 2011 TRUST bought 2,000 shares for $15.76 per share.
Morical Gregory J sold 25,123 shares of CLMT for $419,303 on Jun 16 ’25. The SVP, GENERAL COUNSEL now owns 39,415 shares after completing the transaction at $16.69 per share. On Jun 16 ’25, another insider, Straumins Jennifer, who serves as the Director of the company, sold 100,000 shares for $16.23 each. As a result, the insider received 1,623,000 and left with 934,589 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLMT now has a Market Capitalization of 1179830144 and an Enterprise Value of 3850631936. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.28. Its current Enterprise Value per Revenue stands at 0.946 whereas that against EBITDA is -159.117.
Stock Price History:
The Beta on a monthly basis for CLMT is 0.96, which has changed by -0.22084808 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, CLMT has reached a high of $25.29, while it has fallen to a 52-week low of $7.68. The 50-Day Moving Average of the stock is -15.18%, while the 200-Day Moving Average is calculated to be -17.34%.
Shares Statistics:
The stock has traded on average 1.03M shares per day over the past 3-months and 942330 shares per day over the last 10 days, according to various share statistics. A total of 86.66M shares are outstanding, with a floating share count of 69.25M. Insiders hold about 20.21% of the company’s shares, while institutions hold 51.32% stake in the company. Shares short for CLMT as of 1753920000 were 9678145 with a Short Ratio of 9.41, compared to 1751241600 on 9441328. Therefore, it implies a Short% of Shares Outstanding of 9678145 and a Short% of Float of 14.130001.
Earnings Estimates
Currently, 5.0 analysts are dedicated to thoroughly evaluating and rating the performance of Calumet Inc (CLMT) in the stock market.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.38 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$4.27 and -$4.27 for the fiscal current year, implying an average EPS of -$4.27. EPS for the following year is $0.51, with 2.0 analysts recommending between $0.62 and $0.4.
Revenue Estimates
5 analysts predict $1.06B in revenue for the current quarter. It ranges from a high estimate of $1.25B to a low estimate of $826.6M. As of the current estimate, Calumet Inc’s year-ago sales were $1.1BFor the next quarter, 5 analysts are estimating revenue of $1.06B. There is a high estimate of $1.25B for the next quarter, whereas the lowest estimate is $790.2M.
A total of 5 analysts have provided revenue estimates for CLMT’s current fiscal year. The highest revenue estimate was $4.52B, while the lowest revenue estimate was $3.64B, resulting in an average revenue estimate of $4.14B. In the same quarter a year ago, actual revenue was $4.19BBased on 6 analysts’ estimates, the company’s revenue will be $4.04B in the next fiscal year. The high estimate is $4.79B and the low estimate is $3.14B.
